HealthEquity, Inc. $HQY Shares Sold by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQYFree Report) by 3.2% in the second quarter, HoldingsChannel reports. The firm owned 114,567 shares of the company’s stock after selling 3,842 shares during the quarter. Motley Fool Asset Management LLC’s holdings in HealthEquity were worth $12,002,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC grew its holdings in shares of HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in HealthEquity in the 2nd quarter valued at about $33,000. WPG Advisers LLC acquired a new stake in HealthEquity in the 1st quarter valued at about $28,000. Cullen Frost Bankers Inc. raised its position in HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after purchasing an additional 224 shares in the last quarter. Finally, Sellwood Investment Partners LLC acquired a new stake in HealthEquity in the 2nd quarter valued at about $58,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In other news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, October 20th. The shares were sold at an average price of $92.07, for a total transaction of $138,105.00. Following the completion of the sale, the executive vice president owned 76,979 shares in the company, valued at approximately $7,087,456.53. The trade was a 1.91% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 9,281 shares of company stock valued at $859,867 in the last 90 days. Insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on HQY. JPMorgan Chase & Co. boosted their price target on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, September 3rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. KeyCorp lowered their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Raymond James Financial reiterated a “strong-buy” rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Royal Bank Of Canada boosted their price target on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $121.31.

Read Our Latest Stock Report on HQY

HealthEquity Stock Down 0.3%

Shares of NASDAQ:HQY opened at $96.17 on Tuesday. The company has a market capitalization of $8.29 billion, a PE ratio of 58.29, a P/E/G ratio of 1.39 and a beta of 0.47. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The firm has a 50 day simple moving average of $92.34 and a 200-day simple moving average of $94.76.

HealthEquity (NASDAQ:HQYGet Free Report) last issued its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.